Page last updated: 2024-08-22

lutetium and Carcinoma, Small Cell

lutetium has been researched along with Carcinoma, Small Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlman, H; Bernhardt, P; Forssel-Aronsson, E; Kölby, L; Nilsson, O; Schmitt, A; Schmitt, J	1
Bakker, WH; de Herder, WW; Feelders, RA; Kooij, PP; Krenning, EP; Kwekkeboom, DJ; van Essen, M; Wolbers, JG	1

Other Studies

2 other study(ies) available for lutetium and Carcinoma, Small Cell

Article	Year
Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4 Topics: Algorithms; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Humans; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Octreotide; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Somatostatin; Time Factors; Tissue Distribution	2003
Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10 Topics: Adult; Aged; Carcinoma, Small Cell; Eye Neoplasms; Female; Humans; Lung Neoplasms; Lutetium; Male; Melanoma; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Metastasis; Octreotide; Paraganglioma; Radioisotopes; Radiopharmaceuticals	2006

Article

Year

Biodistribution and dosimetry of 177Lu-labeled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer.

Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4

Topics: Algorithms; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Humans; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Octreotide; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Somatostatin; Time Factors; Tissue Distribution

2003

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10

Topics: Adult; Aged; Carcinoma, Small Cell; Eye Neoplasms; Female; Humans; Lung Neoplasms; Lutetium; Male; Melanoma; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Metastasis; Octreotide; Paraganglioma; Radioisotopes; Radiopharmaceuticals

2006